Emily Talbot

Emily Talbot

Auto-generated profile, based on publicly available information

Emily Talbot

Department of Biochemistry, University of Cambridge , Cambridge , UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ETEmily J Talbot
Emily J Talbot
LJLisha Joshi
Lisha Joshi
PTPeter Thornton
Peter Thornton
MDMahya Dezfouli
Mahya Dezfouli
KTKalliopi Tsafou
Kalliopi Tsafou
SKSvetlana V Khoronenkova
Svetlana V Khoronenkova
Defective DNA damage signalling and repair is a hallmark of age-related and genetic neurodegenerative disease. One mechanism implicated in disease progression is DNA damage-driven neuroinflammation, which is largely mediated by tissue-resident immune cells, microglia. Here, we utilise human microglia-like cell models of persistent DNA damage and ATM kinase deficiency to investigate how genome instability shapes microglial function. We demonstrate that upon DNA damage the cytosolic DNA sensing cGAS-STING axis drives chronic inflammation and a robust chemokine response, exemplified by production of CCL5 and CXCL10. Transcriptomic analyses revealed that cell migratory pathways were highly enriched upon IFN-β treatment of human iPSC-derived microglia, indicating that the chemokine response to DNA damage mirrors type I interferon signalling. Furthermore, we find that STING deletion leads to a defect in microglial chemotaxis under basal conditions and upon ATM kinase loss. Overall, this work provides mechanistic insights into cGAS-STING-dependent neuroinflammatory mechanisms and consequences of genome instability in the central nervous system.

25 February 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JBJulie Bourseguin
Julie Bourseguin
WCWen Cheng
Wen Cheng
ETEmily Talbot
Emily Talbot
LHLiana Hardy
Liana Hardy
JLJenny Lai
Jenny Lai
SKSvetlana V Khoronenkova
Svetlana V Khoronenkova
The autosomal recessive genome instability disorder Ataxia–telangiectasia, caused by mutations in ATM kinase, is characterized by the progressive loss of cerebellar neurons. We find that DNA damage associated with ATM loss results in dysfunctional behaviour of human microglia, immune cells of the central nervous system. Microglial dysfunction is mediated by the pro-inflammatory RELB/p52 non-canonical NF-κB transcriptional pathway and leads to excessive phagocytic clearance of neuronal material. Activation of the RELB/p52 pathway in ATM-deficient microglia is driven by persistent DNA damage and is dependent on the NIK kinase. Activation of non-canonical NF-κB signalling is also observed in cerebellar microglia of individuals with Ataxia–telangiectasia. These results provide insights into the underlying mechanisms of aberrant microglial behaviour in ATM deficiency, potentially contributing to neurodegeneration in Ataxia–telangiectasia.

23 January 2018 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
RDRhiannon David
Rhiannon David
ETEmily Talbot
Emily Talbot
BABethany Allen
Bethany Allen
AWAmy Wilson
Amy Wilson
UAUsman Arshad
Usman Arshad
ADAnn Doherty
Ann Doherty

27 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ETEmily J. Talbot
Emily J. Talbot
LJLisha Joshi
Lisha Joshi
PTPeter Thornton
Peter Thornton
MDMahya Dezfouli
Mahya Dezfouli
KTKalliopi Tsafou
Kalliopi Tsafou
SKSvetlana V. Khoronenkova
Svetlana V. Khoronenkova
Defective DNA damage signalling and repair is a hallmark of age-related and genetic neurodegenerative disease. One mechanism implicated in disease progression is DNA damage-driven neuroinflammation, which is largely mediated by tissue-resident immune cells, microglia. Here, we utilise human microglia-like cell models of persistent DNA damage and ATM kinase deficiency to investigate how genome instability shapes microglial function. We demonstrate that upon DNA damage the cytosolic DNA sensing cGAS-STING axis drives chronic inflammation and a robust chemokine response, exemplified by production of CCL5 and CXCL10. Transcriptomic analyses revealed that cell migratory pathways were highly enriched upon IFN-β treatment of human iPSC-derived microglia, indicating that the chemokine response to DNA damage mirrors type I interferon signalling. Furthermore, we find that STING deletion leads to a defect in microglial chemotaxis under basal conditions and upon ATM kinase loss. Overall, this work provides mechanistic insights into cGAS-STING-dependent neuroinflammatory mechanisms and consequences of genome instability in the central nervous system.

2 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJulie Bourseguin
Julie Bourseguin
WCWen Cheng
Wen Cheng
ETEmily Talbot
Emily Talbot
LHLiana Hardy
Liana Hardy
SKSvetlana V. Khoronenkova
Svetlana V. Khoronenkova
The autosomal recessive genome instability disorder Ataxia-telangiectasia, caused by mutations in ATM kinase, is characterised by the progressive loss of cerebellar neurons. We find that DNA damage associated with ATM loss results in dysfunctional behaviour of human microglia, immune cells of the central nervous system. Microglial dysfunction is mediated by the pro-inflammatory RELB/p52 non-canonical NF-κB transcriptional pathway and leads to excessive phagocytic clearance of neurites. Pathological phagocytosis of neuronal processes by microglia has also been observed in multiple sclerosis, Alzheimer’s and progranulin deficiency, suggesting a common mechanism that promotes neuronal damage. Activation of the RELB/p52 pathway in ATM-deficient microglia is driven by persistent DNA damage and is dependent on the NIK kinase. These results provide insights into the underlying mechanisms of aberrant microglial behaviour in Ataxia-telangiectasia, potentially contributing to neurodegeneration.